The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Aberrant NFAT2 signaling in chronic lymphocytic leukemia.
Jonas S. Heitmann
No relevant relationships to disclose
Melanie Maerklin
No relevant relationships to disclose
Alexandra Poljak
No relevant relationships to disclose
Bettina Hackl
No relevant relationships to disclose
Juliane Stickel
No relevant relationships to disclose
Lothar Kanz
No relevant relationships to disclose
Hans-Georg Kopp
No relevant relationships to disclose
Stefan Wirths
No relevant relationships to disclose
Martin Rudolf Mueller
No relevant relationships to disclose